Skip to main content
SpringerLink
Log in

Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area

  • Published:
Diabetologia Aims and scope Submit manuscript

Summary

Still under debate is the prevalence of microalbuminuria in patients with recently diagnosed Type 2 (non-insulin-dependent) diabetes mellitus and its relation to existing macro-vascular disease and the major vascular risk markers. Hence, from a representative sample of 1512 patients with Type 2 diabetes of varied duration (recruited from 22 nonspecialized medical practices of the Greater Munich Area) 68 (26 males, 42 females) of 71 eligible subjects with a known duration of diabetes of up to 17 weeks and not less than 4 weeks were examined in the present study. Median age was 61 (39 to 75) years, prevalence of ischaemic heart disease (case history plus ECG, Minnesota code, Whitehall criteria) 41.2%, and that of peripheral vascular and carotid artery disease (both assessed by ultrasound-Doppler) were 35.3 and 4.4%, respectively. Diabetes was well controlled (HbA1c: 6.9%, 5.6–8.3; fasting blood glucose: 7.7 mmol/l, 5.4–10.4; median±interquartile range IQ), the cardiovascular risk profile was most prominent in terms of triglycerides (3.1 mmol/l, 2.1–4.6, median±IQ range) and systolic blood pressure (164 mm Hg, 140–186, median±IQ range). 13.2% showed signs of urinary tract infection. Of the remainder, 19.0% exhibited microalbuminuria (RIA, >30–200 mg/l), and 5.2% macroalbuminuria (>200 mg/l). Significant correlations (p<0.05) were found between urinary albumin concentration and β2-microglobubin in serum, systolic blood pressure, serum triglycerides, serum HDL-cholesterol (inversely), HbA1c, and peripheral vascular disease. The results suggest a high prevalence of increased urinary albumin excretion in recently diagnosed Type 2 diabetic patients and a close relationship with several hallmarks of the so-called metabolic syndrome, probably operative in the pre-clinical state of Type 2 diabetes. Based on these observations, increased albuminuria could be a marker of early and accelerated atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 310:356–360

    CAS  PubMed  Google Scholar 

  2. Jarrett RJ, Viberti CG, Argyropoulos A (1984) Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabetic Med 1:17–19

    CAS  PubMed  Google Scholar 

  3. Schmitz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin dependent diabetes. A 10 year follow up study of 503 patients. Diabetic Med 5:126–134

    CAS  PubMed  Google Scholar 

  4. Mattock MB, Morrish NJ, Viberti GC et al. (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41:736–741

    CAS  PubMed  Google Scholar 

  5. Mogensen CE (1989) Microalbuminuria and diabetic renal disease. In: Mogensen CE, Standl E (ed) Prevention and treatment of diabetic late complications. Diabetes Forum Series, Vol 2. De Gruyter. Berlin New York pp 41–73

    Google Scholar 

  6. Viberti GC (1988) Etiology and prognostic significance of albuminuria in diabetes. Diabetes Care 11:840–845

    CAS  PubMed  Google Scholar 

  7. Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Study. Lancet II:580–583

    Google Scholar 

  8. Damsgaard EM, Froland A, Jorgensen OD et al. (1990) Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297–300

    CAS  PubMed  Google Scholar 

  9. Uusitupa M, Niskanen LK, Siitonen O, Pyörälä K (1987) Hyperinsulinemia and hypertension in patients with newly diagnosed non-insulin-dependent diabetes. Diab Metab 13:369–374

    CAS  Google Scholar 

  10. Hanefeld M, Fischer S, Schmechel J et al. (1991) Diabetes intervention study. Multiintervention trial in newly diagnosed NIDDM. Diabetes Care 14:308–317

    CAS  PubMed  Google Scholar 

  11. Uusitupa M, Niskanen LK, Siitonen O et al. (1990) 5 year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 82:27–36

    CAS  PubMed  Google Scholar 

  12. Standl E, Stiegler H, Janka HU, Mehnert H (1988) Risk profile of macrovascular disease in diabetes mellitus. Diab Metabol 14: 505–511

    Google Scholar 

  13. Standl E, Janka HU, Stiegler H, Mehnert H (1992) Hyperinsulinemia and macrovascular complications in NIDDM. In: Lefebvre PJ, Standl E (eds) New aspects in diabetes. De Gruyter, Berlin New York pp 87–95

    Google Scholar 

  14. Standl R, Stiegler H, Rebell B et al. (1990) Der Typ-II-Diabetes in der Praxis des niedergelassenen Arztes: Konzept einer zentrumsunterstützten Betreuung und Ergebnisse einer Stichproben-Erhebung im Großraum München. Akt Endokr Stoffw 11:222–227

    Google Scholar 

  15. WHO Study Group (1985) Diabetes mellitus. Technical report series 727. WHO, Geneva pp 1–113

    Google Scholar 

  16. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary heart disease risk and impaired glucose tolerance: the Whitehall study. Lancet I:1373–1376

    Google Scholar 

  17. Köhler M, Roth FJ, El-Mamoun B (1982) Untersuchungen über die Spezifität der peripheren systolischen Druckmessung mit der Ultraschall-Doppler-Technik an gesunden angiographierten Extremitäten. Z Kardiol 71:156–162

    Google Scholar 

  18. Kriessmann A, Bollinger A, Keller H (eds) (1982) Praxis der Doppler-Sonographie. Thieme, Stuttgart pp 1–51

    Google Scholar 

  19. Bergmeyer HU (ed) (1985) Methods of enzymatic analysis 3rd edn. VCH Verlagsgemeinschaft, Weinheim

    Google Scholar 

  20. Damsgaard EM, Mogensen CE (1986) Microalbuminuria in elderly hyperglycemic patients and controls. Diabetic Med 3:430–435

    CAS  PubMed  Google Scholar 

  21. Uusitupa M, Siitonen O, Penttilä I, Ara A, Pyörälä K (1987) Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care 10:191–194

    CAS  PubMed  Google Scholar 

  22. Patrick AW, Leslie PJ, Clarke BF, Frier BM (1990) The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabetic Med 7:902–908

    CAS  PubMed  Google Scholar 

  23. Cull CA, Manley SE, Turner RC (1992) Non-progression of microalbuminuria over 3 years in 740 type 2 (non-insulin-dependent) diabetic patients. Diabetologia 35[Suppl 1]:A61 (Abstract)

    Google Scholar 

  24. Collins VR, Dowse GK, Finck CF, Zimmet PZ, Linnane AW (1989) Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 38:1602–1610

    CAS  PubMed  Google Scholar 

  25. Gatling W, Mullee MA, Knight C, Hill RD (1988) Microalbuminuria in diabetes: relationships between urinary albumin excretion and diabetes-related variables. Diabetic Med 5:548–551

    Google Scholar 

  26. Eschwege E, Richard JL, Thibult N et al. (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res 15 [Suppl]:41–46

    CAS  Google Scholar 

  27. Fontbonne A, Eschwege E, Cambien F et al. (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow up of the Paris Prospective Study. Diabetologia 32:300–304

    Article  CAS  PubMed  Google Scholar 

  28. Janka HU, Balletshofer B, Becker A et al. (1992) The metabolic syndrome as a potent risk factor for premature death in NIDDM: The Schwabing Study — 9 year follow up. Diab Stoffw 1:2–7

    Google Scholar 

  29. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607

    CAS  PubMed  Google Scholar 

  30. Lebovitz HE (1992) Syndrome X: fact or fiction? In: Lefebvre PJ, Standl E (ed) New aspects in diabetes. De Gruyter, Berlin New York pp 23–33

    Google Scholar 

  31. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992) Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715–722

    CAS  PubMed  Google Scholar 

  32. Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 321:337–343

    CAS  PubMed  Google Scholar 

  33. Zavaroni T, Bonora E, Pagliara M et al. (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702–706

    CAS  PubMed  Google Scholar 

  34. Hasslacher C, Wolfram M, Steck G, Wahl P, Ritz E (1987) Einfluß von Stoffwechselkontrolle und Blutdruck auf Entwicklung und Verlauf der diabetischen Nephropathie bei Typ-II-Diabetes. Deutsch Med Wochenschr 112:1145–1149

    Google Scholar 

  35. Mattock MB, Keen H, Viberti GC et al. (1988) Coronary heart diesease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:82–87

    Article  CAS  PubMed  Google Scholar 

  36. Niskanen M, Uusitupa M, Sarlund H et al. (1990) Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (noninsulin-dependent) diabetic patients. Diabetologia 33:237–243

    Article  CAS  PubMed  Google Scholar 

  37. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W (1992) Morbidity, mortality, and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabetic Med 9:646–653

    CAS  PubMed  Google Scholar 

  38. Nathan DM, Rosenbaum C, Protascowicki VD (1987) Single voil urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 10:414–418

    CAS  PubMed  Google Scholar 

  39. Gruden G, Pasetti V, Estivi P et al. (1992) Albumin excretion rate in non-diabetic offspring of type 2 diabetic patients. Diabetologia 35 [Suppl 1]: A61 (Abstract)

    Google Scholar 

  40. Forsblom C, Ekstrand A, Eriksson J et al. (1992) Microalbuminuria in non-diabetic first degree relatives of type 2 diabetic patients. Diabetologia 35 [Suppl 1]:A61 (Abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Diabetes Research and Third Medical Department, City Hospital Schwabing, Munich, Germany

    E. Standl & H. Stiegler

  2. 3rd Medical Department and Diabetes Research Unit, City Hospital Schwabing, Koelner Platz 1, D-80804, München, Germany

    E. Standl

Authors
  1. E. Standl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Stiegler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Standl, E., Stiegler, H. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area. Diabetologia 36, 1017–1020 (1993). https://doi.org/10.1007/BF02374493

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02374493

Key words

Search

Navigation